Table 1.
miRNA expression in B6.Sle123 B and T lymphocytes
miRNA | 2 mo. (mild disease) | 6 mo. (moderate disease) | 12 mo. (severe disease) | |||
---|---|---|---|---|---|---|
RQ1 ± SEM | p-value | RQ1 ± SEM | p-value | RQ1 ± SEM | p-value | |
A. Differential miRNA expression in B6.Sle123 splenic B Cells | ||||||
miR-21 | 1.7 ± 0.15 | 0.001 | 2.2 ± 0.42 | 0.036 | 5.8 ± 0.64 | 0.016 |
miR-34a | 0.9 ± 0.38 | 0.670 | 1.2 ± 1.33 | 0.821 | 13.2 ± 0.65 | 0.000 |
miR-146a | 1.0 ± 0.51 | 0.996 | 0.6 ± 0.25 | 0.044 | 5.3 ± 0.75 | 0.032 |
miR-221 | 1.2 ± 0.29 | 0.504 | 1.2 ± 0.28 | 0.398 | 13.3 ± 1.05 | 0.023 |
miR-222 | 1.4 ± 0.22 | 0.040 | 2.1 ± 0.26 | 0.015 | 5.8 ± 0.96 | 0.037 |
miR-223 | 0.9 ± 0.53 | 0.720 | 2.3 ± 1.61 | 0.507 | 11.4 ± 0.68 | 0.006 |
miR-142-5p | 1.1 ± 0.21 | 0.374 | 0.4 ± 0.34 | 0.017 | 2.7 ± 0.45 | 0.032 |
miR-155 | 1.3 ± 0.12 | 0.026 | 1.2 ± 0.39 | 0.504 | 2.8 ± 0.53 | 0.050 |
miR-150 | 0.7 ± 0.45 | 0.314 | 0.5 ± 0.27 | 0.098 | 0.5 ± 0.18 | 0.006 |
miR-181a | 0.5 ± 0.20 | 0.007 | 0.3 ± 0.78 | 0.069 | 0.4 ± 0.36 | 0.020 |
B. Differential miRNA expression in B6.Sle123 splenic naïve T cells | ||||||
miR-21 | 2.5 ± 0.37 | 0.012 | 3.6 ± 1.00 | 0.110 | 3.0 ± 0.58 | 0.032 |
miR-34a | 1.5 ± 0.91 | 0.528 | 4.2 ± 1.05 | 0.094 | 6.2 ± 0.50 | 0.006 |
miR-146a | 1.0 ± 1.20 | 0.955 | 4.9 ± 1.56 | 0.216 | 4.1 ± 0.31 | 0.002 |
miR-221 | 0.3 ± 0.47 | 0.013 | 2.3 ± 1.40 | 0.433 | 4.0 ± 0.39 | 0.002 |
miR-222 | 0.6 ± 0.49 | 0.187 | 1.2 ± 0.50 | 0.672 | 0.5 ± 0.20 | 0.006 |
miR-223 | 1.2 ± 0.55 | 0.697 | 4.6 ± 0.58 | 0.019 | 11.1 ± 0.23 | 0.000 |
miR-142-5p | 1.0 ± 0.33 | 0.906 | 1.3 ± 0.56 | 0.550 | 2.6 ± 0.46 | 0.027 |
miR-155 | 0.5 ± 0.12 | 0.000 | 2.1 ± 1.40 | 0.475 | 2.1 ± 0.17 | 0.000 |
miR-150 | 1.0 ± 0.84 | 0.943 | 0.7 ± 0.69 | 0.553 | 0.6 ± 0.22 | 0.008 |
miR-181a | 1.4 ± 0.77 | 0.562 | 1.0 ± 0.97 | 0.980 | 0.2 ± 0.66 | 0.015 |
C. Differential miRNA expression in B6.Sle123 splenic memory T cells | ||||||
miR-21 | 2.3 ± 0.26 | 0.00371 | 2.3 ± 0.32 | 0.00935 | 2.9 ± 0.31 | 0.00734 |
miR-34a | 1.2 ± 0.46 | 0.61619 | 2.8 ± 0.98 | 0.17000 | 6.1 ± 1.0 | 0.03999 |
miR-146a | 2.0 ± 0.27 | 0.00815 | 1.9 ± 0.23 | 0.00692 | 1.8 ± 0.31 | 0.03301 |
miR-221 | 0.9 ± 0.29 | 0.78955 | 2.2 ± 0.33 | 0.02462 | 3.5 ± 0.59 | 0.01522 |
miR-222 | 3.0 ± 0.66 | 0.04896 | 2.5 ± 0.39 | 0.02568 | 4.7 ± 0.91 | 0.03822 |
miR-223 | 1.1 ± 0.44 | 0.80584 | 1.7 ± 0.14 | 0.00425 | 5.3 ± 0.89 | 0.02602 |
miR-142-5p | 1.2 ± 0.22 | 0.35640 | 1.3 ± 0.39 | 0.38912 | 0.9 ± 0.52 | 0.72454 |
miR-155 | 0.1 ± 0.86 | 0.02879 | 1.3 ± 0.30 | 0.91145 | 0.1 ± 0.31 | 0.00023 |
miR-150 | 1.3 ± 0.36 | 0.34351 | 1.1 ± 0.50 | 0.80519 | 1.0 ± 0.68 | 0.92495 |
miR-181a | 0.8 ± 0.33 | 0.49138 | 0.9 ± 0.98 | 0.93433 | 0.2 ± 0.79 | 0.01509 |
A. CD19+ splenic B cells from individual B6.Sle123 and age- and gender-matched B6 mice at 2, 6 and 12 months of age were FACS purified. Twenty nanograms total B cell RNA were reverse-transcribed with TaqMan miRNA-specific reverse-transcription primers followed by quantification using Taqman miRNA-specific qRT-PCR assays. B6.Sle123 miRNA RQ values represent the average of triplicate measurements from at least three independent experiments in individual B6.Sle123 mice relative to the expression of the same miRNA in individual B6 B cells. Prior to obtaining RQ values, the Ct values for each miRNA in each sample, were normalized against sno429 expression (ΔCt). The mean B6.Sle123 miRNA RQ was calculated by evaluating where ΔΔCt = ΔCt Sle123 ave − ΔCt B6 ave.
B. As in A except total splenic CD44Low CD62LHigh naïve T cells were FACS purified from individual mice.
C. As in A except total splenic CD44High CD62LLow memory T cells were FACS purified from individual mice.